Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rudà R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gørløv JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).
Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6.
Case report: Rapid resolution of grade IV ICANS after first line intrathecal chemotherapy with methotrexate, cytarabine and dexamethasone.
Katsin M, Shman T, Migas A, Lutskovich D, Serada Y, Khalankova Y, Kostina Y, Dubovik S.
Front Immunol. 2024 May 3;15:1380451. doi: 10.3389/fimmu.2024.1380451. eCollection 2024.
Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia.
Levinsen M, Harila-Saari A, Grell K, Jonsson OG, Taskinen M, Abrahamsson J, Vettenranta K, Åsberg A, Risteli J, Heldrup J, Schmiegelow K.
J Pediatr Hematol Oncol. 2016 Nov;38(8):602-609. doi: 10.1097/MPH.0000000000000642.
Central nervous system toxicities of chemotherapeutic agents.
Peddi PF, Peddi S, Santos ES, Morgensztern D.
Expert Rev Anticancer Ther. 2014 Jul;14(7):857-63. doi: 10.1586/14737140.2014.911089. Epub 2014 Apr 21.
Combination chemotherapy in malignant diseases.
Fairley GH.
J R Coll Physicians Lond. 1971 Jan;5(2):167-77.
Protective effect of alpha-lipoic acid against in utero cytarabine exposure-induced hepatotoxicity in rat female neonates.
Namoju R, Chilaka KN.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6577-6589. doi: 10.1007/s00210-024-03036-4. Epub 2024 Mar 9.
Neurologic toxicities of cancer therapies.
Cavaliere R, Schiff D.
Curr Neurol Neurosci Rep. 2006 May;6(3):218-26. doi: 10.1007/s11910-006-0009-8.
Cytarabine-induced neurotoxicity responding to methyl prednisolone.
Malhotra P, Mahi S, Lal V, Kumari S, Jain S, Varma S.
Am J Hematol. 2004 Dec;77(4):416. doi: 10.1002/ajh.20171.
Clinical management of cytotoxic drug overdose.
Thomas LL, Mertens MJ, von dem Borne AE, van Boxtel CJ, Veenhof CH, Veies EP.
Med Toxicol Adverse Drug Exp. 1988 Jul-Aug;3(4):253-63. doi: 10.1007/BF03259938.
Standard therapy of advanced Hodgkin lymphoma.
Kuruvilla J.
Hematology Am Soc Hematol Educ Program. 2009:497-506. doi: 10.1182/asheducation-2009.1.497.
